|
Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial |
|
|
|
Titel: |
Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial |
Auteur: |
Mazeraud, Aurélien Jamme, Matthieu Mancusi, Rossella Letizia Latroche, Claire Megarbane, Bruno Siami, Shidasp Zarka, Jonathan Moneger, Guy Santoli, Francesco Argaud, Laurent Chillet, Patrick Muller, Gregoire Bruel, Cedric Asfar, Pierre Beloncle, Francois Reignier, Jean Vinsonneau, Christophe Schimpf, Caroline Amour, Julien Goulenok, Cyril Lemaitre, Caroline Rohaut, Benjamin Mateu, Philippe De Rudnicki, Stephane Mourvillier, Bruno Declercq, Pierre-Louis Schwebel, Carole Stoclin, Annabelle Garnier, Marc Madeux, Benjamin Gaudry, Stéphane Bailly, Karine Lamer, Christian Aegerter, Philippe Rieu, Christine Sylla, Khaoussou Lucas, Bruno Sharshar, Tarek |
Verschenen in: |
Lancet respiratory medicine |
Paginering: |
Jaargang 10 () nr. 2 pagina's 158-166 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|